Oclaro, Inc. has announced that the company has shipped 200,000th Fluorescence Filter for biomedical and analytical instrumentation markets. The company's Oclaro filters are used in clinical diagnostics, drug discovery, gene quantification, blood analysis, and disease detection. At LASER World of Photonics 2009 in Munich, the latest offerings from the Oclaro filter portfolio will be displayed.
Uisng Advanced Energetic Deposition coating technology, Oclaro Clarity Filters produce high performance band pass filters, dichroic mirrors, and laser beam combiners. An environmentally stable hard coating offers superb resistance, high transmission, and high out-of-band blocking.
Oclaro Fluorescence Filters are based on proven telecom technology boasting zero failures in over 65 billion recorded hours of operation, said Yves LeMaitre, EVP and General Manager of the Oclaro Advanced Photonic Solutions (APS) division. We have been manufacturing Clarity Fluorescence Filters for the biomedical market for over five years and have the expertise to deliver quality, innovative products to this demanding and dynamic market.